Stock VRAYQ VIEWRAY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases ViewRay, Inc.

Equities

VRAYQ

US92672L1070

Market Closed - OTC Markets
Other stock markets
 03:34:45 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for ViewRay, Inc. -.--% -.--%
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ
Mar. 12 Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TeamBest Global Companies - Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
AQ
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets
PR
ViewRay® Files Voluntary Chapter 11 Petitions
PR
ViewRay : Failure to Satisfy Listing Rule - Form 8-K
PU
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System
PR
ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting
PR
ViewRay: Q1 Earnings Snapshot
AQ
VIEWRAY, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
ViewRay Announces First Quarter 2023 Results
PR
ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023
PR
VIEWRAY, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value
PR
ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023
PR
VIEWRAY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients
PR
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy
PR
VIEWRAY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
ViewRay: Q4 Earnings Snapshot
AQ
VIEWRAY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
ViewRay : Appendix
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VRAYQ Stock
  4. News ViewRay, Inc.
  5. Press Releases